Charles River Laboratories Other Current Assets 2010-2024 | CRL

Charles River Laboratories other current assets from 2010 to 2024. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Charles River Laboratories other current assets for the quarter ending September 30, 2024 were $0.102B, a 8.79% increase year-over-year.
  • Charles River Laboratories other current assets for 2023 were $0.083B, a 22.5% decline from 2022.
  • Charles River Laboratories other current assets for 2022 were $0.108B, a 10.55% increase from 2021.
  • Charles River Laboratories other current assets for 2021 were $0.097B, a 34.11% increase from 2020.
Charles River Laboratories Annual Other Current Assets
(Millions of US $)
2023 $83
2022 $108
2021 $97
2020 $73
2019 $56
2018 $49
2017 $81
2016 $45
2015 $47
2014 $45
2013 $87
2012 $84
2011 $79
2010 $77
2009 $112
Charles River Laboratories Quarterly Other Current Assets
(Millions of US $)
2024-09-30 $102
2024-06-30 $111
2024-03-31 $99
2023-12-31 $83
2023-09-30 $93
2023-06-30 $113
2023-03-31 $92
2022-12-31 $108
2022-09-30 $97
2022-06-30 $107
2022-03-31 $82
2021-12-31 $97
2021-09-30 $247
2021-06-30 $122
2021-03-31 $72
2020-12-31 $73
2020-09-30 $74
2020-06-30 $65
2020-03-31 $62
2019-12-31 $56
2019-09-30 $77
2019-06-30 $69
2019-03-31 $56
2018-12-31 $49
2018-09-30 $43
2018-06-30 $50
2018-03-31 $53
2017-12-31 $81
2017-09-30 $86
2017-06-30 $68
2017-03-31 $44
2016-12-31 $45
2016-09-30 $53
2016-06-30 $67
2016-03-31 $62
2015-12-31 $47
2015-09-30 $84
2015-06-30 $74
2015-03-31 $111
2014-12-31 $45
2014-09-30 $107
2014-06-30 $108
2014-03-31 $88
2013-12-31 $87
2013-09-30 $105
2013-06-30 $93
2013-03-31 $93
2012-12-31 $84
2012-09-30 $65
2012-06-30 $75
2012-03-31 $81
2011-12-31 $79
2011-09-30 $78
2011-06-30 $89
2011-03-31 $89
2010-12-31 $77
2010-09-30 $72
2010-06-30 $74
2010-03-31 $74
2009-12-31 $112
2009-09-30 $61
2009-06-30 $109
2009-03-31 $103
Sector Industry Market Cap Revenue
Medical Medical Services $9.517B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $88.397B 10.97
Cencora (COR) United States $45.651B 17.16
Natera (NTRA) United States $23.104B 0.00
DiDi Global (DIDIY) China $21.969B 0.00
ICON (ICLR) Ireland $18.002B 16.03
Avantor (AVTR) United States $14.742B 22.10
Viatris (VTRS) United States $13.929B 4.29
Revvity (RVTY) United States $13.859B 24.08
BioMerieux (BMXMF) France $12.558B 0.00
CochLear (CHEOY) Australia $12.074B 0.00
Solventum (SOLV) United States $11.587B 0.00
Medpace Holdings (MEDP) United States $10.906B 30.72
Doximity (DOCS) United States $9.727B 57.25
EUROFINS SCIENT (ERFSF) Luxembourg $9.707B 0.00
HealthEquity (HQY) United States $8.694B 43.62
Sonic Healthcare (SKHHY) Australia $8.191B 0.00
Bausch + Lomb (BLCO) Canada $6.259B 29.11
Amplifon S.p.A (AMFPF) Italy $5.864B 29.89
Organon (OGN) United States $4.082B 4.12
Sotera Health (SHC) United States $3.713B 19.86
BrightSpring Health Services (BTSG) United States $2.990B 63.59
Surgery Partners (SGRY) United States $2.625B 29.93
Concentras Parent (CON) United States $2.513B 0.00
GeneDx Holdings (WGS) United States $2.455B 0.00
Alignment Healthcare (ALHC) United States $2.277B 0.00
Ardent Health Partners (ARDT) United States $2.255B 0.00
Premier (PINC) United States $2.006B 10.44
PACS (PACS) United States $1.955B 0.00
GoodRx Holdings (GDRX) United States $1.734B 45.50
Teladoc Health (TDOC) United States $1.699B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.658B 0.00
Progyny (PGNY) United States $1.597B 32.34
Establishment Labs Holdings (ESTA) $1.282B 0.00
CareDx (CDNA) United States $1.267B 0.00
Embecta (EMBC) United States $1.132B 7.92
Pediatrix Medical (MD) United States $1.068B 10.45
AMN Healthcare Services Inc (AMN) United States $1.023B 6.93
Agilon Health (AGL) United States $1.001B 0.00
QDM (QDMI) Hong Kong, SAR China $0.563B 14.73
SBC Medicals (SBC) United States $0.526B 0.00
Auna S.A (AUNA) Luxembourg $0.526B 0.00
InnovAge Holding (INNV) United States $0.490B 0.00
DocGo (DCGO) United States $0.416B 15.69
Sonida Senior Living (SNDA) United States $0.409B 0.00
Enhabit (EHAB) United States $0.382B 33.04
COMPASS Pathways (CMPS) United Kingdom $0.242B 0.00
Sera Prognostics (SERA) United States $0.234B 0.00
MultiPlan (MPLN) United States $0.206B 0.00
LifeMD (LFMD) United States $0.205B 0.00
Performant Healthcare (PHLT) United States $0.197B 0.00
Beauty Health (SKIN) United States $0.192B 0.00
Biodesix (BDSX) United States $0.185B 0.00
Nutex Health (NUTX) United States $0.168B 0.00
So-Young (SY) China $0.104B 17.70
ModivCare (MODV) United States $0.094B 5.09
Ascend Wellness Holdings (AAWH) United States $0.092B 0.00
IceCure Medical (ICCM) Israel $0.072B 0.00
NeueHealth (NEUE) United States $0.061B 1.61
Singular Genomics Systems (OMIC) United States $0.049B 0.00
OncoCyte (OCX) United States $0.037B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.035B 0.00
Co-Diagnostics (CODX) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.026B 0.00
Oncology Institute (TOI) United States $0.023B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
KindlyMD (KDLY) United States $0.009B 0.00
XWELL (XWEL) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
NewGenIvf Group (NIVF) Thailand $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Aclarion (ACON) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00